Akèy › Myelom Miltip › New Jersey › Edison
Etid klinik pou Myelom Miltip nan Edison, NJ
22 etid pou Myelom Miltip ap chèche patisipan nan sit nan ak bò kote Edison (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
Ap rekriteFaz 3
- Astera Cancer Care, East Brunswick · 6 mi lwen
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
Ap rekriteFaz 3
- MSK Basking Ridge, Basking Ridge · 15 mi lwen
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Ap rekriteFaz 3
- Astera Cancer Care, East Brunswick · 6 mi lwen
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
Ap rekriteFaz 4
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi lwen
Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
Ap rekriteFaz 2
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · 15 mi lwen
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
Ap rekriteFaz 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi lwen
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
Ap rekriteFaz 3
- MSK Basking Ridge, Basking Ridge · 15 mi lwen
A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma
Ap rekriteFaz 1
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi lwen
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
Ap rekriteFaz 3
- Research Site, East Brunswick · 6 mi lwen
A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy
Ap rekriteEtid obsèvasyon
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi lwen
A Study of Dara-RVd and Teclistamab-RVd in People With Multiple Myeloma
Ap rekriteFaz 1/2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi lwen
A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)
Ap rekriteFaz 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi lwen
A Study of Elranatamab and Cyclophosphamide in People With Multiple Myeloma
Ap rekriteFaz 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi lwen
Loratadine for the Reduction of G-CSF Induced Bone Pain in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization
Ap rekriteFaz 1 bonè
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi lwen
- RWJBarnabas Health - Robert Wood Johnson University Hospital, New Brunswick, New Brunswick · 3 mi lwen
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
Ap rekriteFaz 1/2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi lwen
Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma
Ap rekriteFaz 1
- Rutgers Cancer Institute of New Jersey /ID# 266833, New Brunswick · 3 mi lwen
A Dietary Study for People With Multiple Myeloma
Ap rekrite
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi lwen
A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant
Ap rekriteFaz 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi lwen
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Ap rekriteFaz 1/2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi lwen
A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy
Ap rekriteFaz 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi lwen
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi lwen
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
Ap rekrite
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · 15 mi lwen
Etid Myelom Miltip nan lòt vil
- New York City, NY60 etid
- Boston, MA42 etid
- Atlanta, GA41 etid
- Houston, TX38 etid
- Durham, NC37 etid
- Nashville, TN32 etid
- Denver, CO26 etid
- Columbus, OH24 etid
- Rochester, MN24 etid
- Baldwin Park, CA23 etid
- St. Louis, MO23 etid
- Washington, DC22 etid
Lòt etid nan Edison
- Kansè nan tete69 etid
- Kansè Poumon ki pa ti selil47 etid
- Kansè (tout kalite)33 etid
- Kansè pwostat30 etid
- Kansè kolorektal24 etid
- Kansè poumon24 etid
- Kansè vejik22 etid
- Leksemi mieloïd egi21 etid
- Kansè Endomèt20 etid
- Kansè ovè20 etid
- Kansè Metastatik19 etid
- Kasinom Selil Transizyonèl (Urotelyal)18 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.